Ellen Bold Jaeger

Employment

• Tempus Labs (United States) Biostatistician
  2022 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers
  Cancers 2025 DOI: 10.3390/cancers17091432
  +Save
• ESR1 Y537S and D538G mutations drive resistance to CDK4/6 inhibitors in estrogen receptor-positive breast cancer
  Clinical Cancer Research 2025 DOI: 10.1158/1078-0432.ccr-24-2307
  +Save
• Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies
  Cancers 2024 DOI: 10.3390/cancers16101823
  +Save
• Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab
  The oncologist 2023 DOI: 10.1093/oncolo/oyac203
  +Save
• Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience
  Clinical Genitourinary Cancer 2023 DOI: 10.1016/j.clgc.2022.10.007
  +Save
• Clinical and molecular determinants of PSA response to bipolar androgen therapy in prostate cancer
  Prostate 2023 DOI: 10.1002/pros.24529
  +Save
• Comparison of circulating tumor DNA between African American and Caucasian patients with metastatic castrate-resistant prostate cancer post-abiraterone and/or enzalutamide
  Prostate 2023 DOI: 10.1002/pros.24544
  +Save
• Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR-altered lethal prostate cancer
  medRxiv 2023 DOI: 10.1101/2023.12.01.23299215
  +Save
• Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
  Oncologist 2022 DOI: 10.1093/oncolo/oyac176
  +Save
• Continuous IV Infusion of 5-Flourouracil in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer
  Clinical Genitourinary Cancer 2022 DOI: 10.1016/j.clgc.2022.06.014
  +Save
• Multi-institutional Analysis of the Clinical and Genomic Characteristics of Black Patients with Metastatic Hormone-Sensitive Prostate Cancer
  Oncologist 2022 DOI: 10.1093/oncolo/oyab057
  +Save
• The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases
  Prostate 2022 DOI: 10.1002/pros.24375
  +Save
• Bactericidal urea crown ethers target phosphatidylethanolamine membrane lipids
  Organic and Biomolecular Chemistry 2021 DOI: 10.1039/d1ob00263e
  +Save
• Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
  Prostate 2021 DOI: 10.1002/pros.24123
  +Save
• Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients
  Prostate 2021 DOI: 10.1002/pros.24120
  +Save
• Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
  Pedro Coelho Barata, Neeraj Agarwal, Roberto Henrique Nussenzveig +13 more
  Journal for ImmunoTherapy of Cancer 2020 DOI: 10.1136/jitc-2020-001065
  +Save
• Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort
  Frontiers in Oncology 2020 DOI: 10.3389/fonc.2020.581189
  +Save